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Restless legs syndrome (RLS) is a common neurological disorder that affects 5%–12% of all whites. To genetically
dissect this complex disease, we characterized 15 large and extended multiplex pedigrees, consisting of 453 subjects
(134 affected with RLS). A familial aggregation analysis was performed, and SAGE FCOR was used to quantify
the total genetic contribution in these families. A weighted average correlation of 0.17 between ﬁrst-degree relatives
was obtained, and heritability was estimated to be 0.60 for all types of relative pairs, indicating that RLS is a
highly heritable trait in this ascertained cohort. A genomewide linkage scan, which involved 1400 10-cM–spaced
markers and spanned the entire human genome, was then performed for 144 individuals in the cohort. Model-free
linkage analysis identiﬁed one novel signiﬁcant RLS-susceptibility locus on chromosome 9p24-22 with a multipoint
nonparametric linkage (NPL) score of 3.22. Suggestive evidence of linkage was found on chromosome 3q26.31
(NPL score 2.03), chromosome 4q31.21 (NPL score 2.28), chromosome 5p13.3 (NPL score 2.68), and chromosome
6p22.3 (NPL score 2.06). Model-based linkage analysis, with the assumption of an autosomal-dominant mode of
inheritance, validated the 9p24-22 linkage to RLS in two families (two-point LOD score of 3.77; multipoint LOD
score of 3.91). Further ﬁne mapping conﬁrmed the linkage result and deﬁned this novel RLS disease locus to a
critical interval. This study establishes RLS as a highly heritable trait, identiﬁes a novel genetic locus for RLS, and
will facilitate further cloning and identiﬁcation of the genes for RLS.
Introduction
Restless legs syndrome (RLS [MIM 102300]) is a com-
mon sensorimotor disorder that affects 5%–12% of
white populations (Phillips et al. 2000; Rothdach et al.
2000; Ulfberg et al. 2001a, 2001b). Asian and African
populations appear to be less affected (Kageyama et al.
2000; Tan and Ondo 2000). In 1995, the International
Restless Legs Syndrome Study Group (IRLSSG) de-
scribed a set of minimal inclusion criteria for RLS, con-
sisting of four primary features (Walters 1995): (1) an
urge to move the extremities, often because of uncom-
fortable sensations (paresthesia/dysesthesia); (2) motor
restlessness; (3) worsening of symptoms with rest and
at least partial relief during movement; and (4) wors-
ening of symptoms in the evening or night. Amore recent
National Institutes of Health (NIH) consensus statement
provided a modiﬁed version of the criteria: (1) an urge
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to move the limbs with or without paresthesia; (2) wors-
ening of symptoms at rest; (3) at least transient or partial
relief of symptoms with movement; and (4) symptoms
worsening during the evening or night (Allen et al.
2003a, 2003b; Walters et al. 2003). The RLS diagnosis
is based on these entry criteria exclusively (Allen et al.
2003b), although periodic limb movements while asleep
(PLMS) (Montplaisir et al. 1997), a normal neurological
examination, improvement with dopaminergic medica-
tions, and a family history of RLS all support the di-
agnosis. Presentation of symptoms in adolescence or
even infancy is not rare (Picchietti et al. 1998), although
many pediatric patients probably manifest the same con-
dition as adult RLS without meeting the same accepted
diagnostic criteria (Allen et al. 2003b).
The etiology of RLS is not known, but recent CNS
pathology studies demonstrate reduced intracellular,
and possibly extracellular, iron stores (Connor et al.
2003). The actual symptoms of RLS, however, improve
with dopaminergic medications, which implicates a do-
paminergic system in the pathogenesis of RLS (Ondo
and Jankovic 1996). The exact interaction between re-
duced iron and dopaminergic dysfunction is currently
under investigation (Earley et al. 2000; Allen and Earley
2001; Allen et al. 2001).
A family history of RLS is reported by ∼65% of RLS
patients, suggesting the involvement of genetic factors
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Table 1
Summary Statistics of RLS Families
ITEM STATISTIC
No. of pedigrees:
All 15
With 2 generations 1
With 3 generations 5
With 4 generations 7
With 5 generations 2
Mean size of pedigrees 30.2  23.8 (minp7, maxp90)
No. of pairs:
Parent-offspring 634
Sib-sib: 399
Sister-sister 94
Brother-brother 121
Brother-sister 184
Grandparent-grandchild 492
Half-sib 12
No. of subjects:
All 453
Affected 134
Founder 136
Non-founder 317
Male:female ratio 227:226 (50.1%:49.9%)
Table 2
Correlation Coefﬁcients (r) of RLS among Various Relative Pairs
RELATIONSHIP NO. OF PAIRS r
1st-degree relatives: 918 .171**
Parent-offspring: 567 .096**  .033
Father-son 135 .195*  .088
Mother-son 134 .182*  .110
Father-daughter 148 .232**  .087
Mother-daughter 150 .132  .103
Siblings: 351 .291**  .096
Brother-brother 106 .480**  .161
Brother-sister 166 .161  .132
Sister-sister 79 .392**  .122
2nd-degree relatives: 1205 .039
Grandparent-grandchild 439 .032  .051
Avuncular 766 .079  .089
3rd-degree relatives: 1243 .090**
Great-grandparent 184 .015  .078
First cousin 604 .091  .088
Great-avuncular 455 .131  .098
4th-degree relatives: 1412 .0640*
First cousin once removed 920 .067  .073
Second cousin 492 .058  .084
Unrelated spouse 117 .412**  .085
NOTE.—* ; **P ! .05 P ! .01
in the development of RLS (Montplaisir et al. 1997;
Lazzarini et al. 1999; Rothdach et al. 2000; Allen et al.
2002; Winkelmann et al. 2002). It is probable that fe-
males are affected somewhat more than males (Roth-
dach et al. 2000). The ﬁnding that MZ twins are highly
concordant for the presence of RLS also supports the
hypothesis that genetic factors contribute to the path-
ogenesis of RLS (Ondo et al. 2000). Segregation analysis
with RLS families argued for a single major gene acting
in an autosomal-dominant manner with a multifactorial
component (Winkelmann et al. 2002). Nevertheless, as
with other common diseases, RLS may have a polygenic
basis, possibly with mixed contributions of multiplema-
jor genes, modiﬁer genes, and complex interactions of
genes with genes and of genes with environmental fac-
tors. Thus, in this study, we attempted to genetically
analyze RLS as a complex trait. We recruited 15 mul-
tiplex RLS families with 453 subjects (134 affected with
RLS) and did a genomewide scan to identify novel sus-
ceptibility loci for RLS.
Material and Methods
Ascertainment of Multiplex RLS Families
A total of 15 large and extended multiplex RLS fam-
ilies, with a total of 453 subjects, including 134 indi-
viduals affected with RLS, were recruited in North
America for this study. The largest family consisted of
90 members, and the smallest family had 7 members.
All probands were recruited from the patients seen at
the Baylor College of Medicine Movement Disorders
Clinic (W.G.O.). Families were selected if the proband
had at least one ﬁrst-degree relative who was also af-
fected with RLS. We attempted to contact all living ge-
netic relatives within these families, and then a majority
of them (∼75%) were enrolled in this study. Because
recruitment began in 1996, RLS diagnosis was based on
the 1995 IRLSSG criteria (Walters 1995). The phenotype
was not determined on the basis of symptom severity.
All subjects completed written questionnaires (Hening
and Allen 2003) and, subsequently, were interviewed by
a neurologist with particular expertise in RLS (W.G.O.).
These interviews took place at two family-reunions, at
the Baylor College of Medicine, or by phone. The in-
terviewer was not blinded to the family status of the
study subject. Physical examination is not part of the
diagnostic criteria for RLS, but it was performed on
subjects who were interviewed in person. To determine
the secondary causes of RLS, interviewed subjects were
asked whether they had a history of kidney disease, a
history of anemia, a history of damage to the nerves,
and so forth, except in the case of probands, who all
had normal serum ferritin levels. Two probands had mi-
nor neuropathy, but we concluded that it was not related
to the RLS. Subjects who experienced RLS only during
pregnancy were not phenotyped as positive for RLS.
Despite that children may have a different presentation
of symptoms than the presentation seen in adults, chil-
dren were only phenotyped as having RLS if they met
the inclusion criteria for adults. Although patients were
not reinterviewed after publication of the 2003 NIH
criteria (Allen et al. 2003a, 2003b; Walters et al. 2003),
we believe that applying these criteria would not change
the phenotype in any case. Informed consent was ob-
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Table 3
Summary of Chromosomal Regions with an NPL Score 12.0
NPL SCORE
CHROMOSOME
AND MARKER LOCATION
MAP
POSITION
(cM) Multipoint Two-point
3:
D3S2427 3q26.31 188.0 2.03 .75
4:
ATT015 … 26.2 1.76 2.09
D4S1644 4q31.21 143.4 2.28 .98
D4S1625 4q31.21 146.1 2.19 1.40
D4S2417 4q34.3 182.0 2.16 1.00
5:
D5S2505 5p15.32 14.3 2.03 1.07
D5S2845 5p14.3 36.0 2.61 2.25
D5S1470 5p13.3 45.0 2.68 1.68
6:
D6S2439 6p22.3 42.0 2.06 1.16
9:
D9S286 9p24.1 17.9 3.22 3.41
GATA187D09 9p23 22.0 2.87 .60
NOTE.—NPL scores were computed using GENEHUNTER. Allele
frequencies for the markers were estimated as ML, by the use of SAGE
FREQ and the genotyping data generated in this study.
tained from participants in accordance with standards
established by local institutional review boards. The
summary statistics for the 15 multiplex pedigrees are
shown in table 1.
Genotyping
We performed genomewide genotyping for 144 study
subjects from the 15 multiplex RLS families, including
both RLS patients and unaffected family members, on
the basis of DNA-sample availability. Genomic DNA
was prepared fromwhole blood using the DNA Isolation
Kit for Mammalian Blood (Roche Diagnostic). Initial
genotyping was performed by the NHLBI Mammalian
Genotyping Service, directed by Dr. J. Weber, with 404
∼10-cM–spaced polymorphic markers (microsatellite
markers and SNPs) spanning the human genome, with
a maximum gap of 17 cM (Weber and Broman 2001).
Additional genotyping with microsatellite markers was
done in our laboratory, as described elsewhere (Wang et
al. 1995, 1996, 2003; Chen et al. 1998).
Data Preparation
The process of data collection was monitored and su-
pervised by experts in statistical genetics and human
genetics, for suitability of genetic analysis. The RLS dis-
ease phenotype information was updated on a regular
basis and was entered into our database for genetic anal-
ysis of RLS. Prior to the genetic analysis, several rounds
of data cleaning and assurance were performed on the
data set. Obvious locus-order errors and genotyping er-
rors that commonly occur with large-scale genotyping
were corrected (locus-order errors were detected by the
Marshﬁeld NHLBI Genotyping Service). Allele frequen-
cies for the markers in the cohort were estimated ac-
cording to maximum likelihood (ML), with the use of
the SAGE program FREQ (SAGE 2003) and the geno-
typing data generated in this study. Pedigree relationship
was tested using the SAGE RELTEST, which employs a
Markov-process model of allele-sharing along the chro-
mosome and uses genome-scan data to classify pairs of
pedigree members according to their true relationship
(Olson 1999; SAGE 2003). After correcting relation-
ships, SAGE MARKERINFO (SAGE 2003) was used to
detect any Mendelian-inheritance inconsistency for each
marker, and, if detected, then the inconsistent genotyp-
ing data for the marker were removed manually. Inher-
itance inconsistency was detected in one male, and the
individual was excluded from linkage analysis.
Familial Aggregation Analysis
Familial correlations were estimated using SAGE
FCOR (SAGE 2003) to quantify the genetic contribu-
tions in the ascertained multiplex families. FCOR cal-
culates multivariate familial correlations and their as-
ymptotic SEs, for all pair-types available in the RLS
pedigrees, on the basis of the equivalent number of in-
dependent pairs that, theoretically, could have been used
to obtain the same SE for a given correlation (SAGE
2003). The program estimates familial correlations for
both subtypes and main types (groups of subtypes), to-
gether with the corresponding asymptotic SEs derived
from the variance-covariance matrices of the estimated
correlations (SAGE 2003). Correlations for relative pairs
at different levels (the ﬁrst-degree relative pairs to the
fourth-degree relative pairs, etc.) were averaged over all
the types and weighted uniformly (each pair with in-
versely proportional to the number of such pairs in the
pedigrees) (SAGE 2003). These large extended families
provide sufﬁcient information to decompose genetic
components from RLS phenotypic variations. Reliable
estimates for various types of relative pairs can be ob-
tained. As shown in table 1, the recruited pedigrees con-
sist of 1 pedigree with 2 generations, 5 with 3 genera-
tions, 7 with 4 generations, and 2 with 5 generations,
which provide a combined maximum of 634 parent-
offspring pairs, 399 sibling-sibling pairs, and 492 grand-
parent-grandchild pairs. Technically, familial aggrega-
tion analysis is a more detailed version of the mixed
linear model approach, in that each type of relative pair
is estimated separately instead of modeling them as a
function of a few parameters in a single covariance ma-
trix. Historically, familial aggregation analysis has been
the most popular method for determining genetic causes
in disease manifestation. This method, in essence, is to
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Table 4
Pairwise LOD Scores between RLS and Chromosome 9p24-22
Markers Obtained by Model-Based Linkage Analysis in Two
Extended RLS Kindreds
RECOMBINATION FRACTION (V)
MARKER AND KINDRED .00 .05 .10 .20 .30 .40
D9S1779:
40004 .00 .00 .00 .00 .00 .00
40015 1.19 .61 .75 .70 .49 .22
Total 1.19 .61 .75 .70 .49 .22
D9S1871:
40004 .29 .27 .25 .20 .14 .07
40015 1.99 1.83 1.65 1.29 .89 .47
Total 2.28 2.10 1.90 1.49 1.03 .54
D9S2169:
40004 .89 .82 .75 .60 .43 .23
40015 1.91 1.75 1.58 1.21 .83 .41
Total 2.80 2.57 2.33 1.81 1.26 .64
D9S286:
40004 1.79 1.63 1.47 1.11 .72 .32
40015 1.98 1.81 1.64 1.28 .89 .47
Total 3.77 3.44 3.11 2.39 1.61 .79
D9S168:
40004 .00 .00 .00 .00 .00 .00
40015 1.84 1.68 1.51 1.16 .79 .39
Total 1.84 1.68 1.51 1.16 .79 .39
D9S268:
40004 .58 .47 .36 .14 .03 .08
40015 1.54 1.40 1.26 .96 .64 .31
Total 2.12 1.87 1.62 1.10 .61 .23
D9S274:
40004 1.24 1.09 .94 .64 .33 .09
40015 1.98 1.81 1.64 1.28 .89 .47
Total 3.24 2.90 2.58 1.92 1.22 1.56
D9S1839:
40004 .00 .00 .00 .00 .00 .00
40015 .77 .68 .58 .38 .20 .05
Total .77 .68 .58 .38 .20 .05
D9S162:
40004 1.50 1.70 .02 .11 .07 .00
40015 2.02 1.85 1.67 1.30 .90 .47
Total .52 .15 1.69 1.41 .97 .47
D9S1121:
40004 1.50 1.48 1.29 .80 .47 .23
40015 .20 .17 .14 .08 .03 .01
Total 1.30 1.31 1.15 .72 .44 .22
NOTE.—LOD scores were computed with the assumption of 95%
penetrance and a gene frequency of 0.001. The allele frequencies of
markers were 1/n, where n is the number of alleles observed.
estimate the correlations between various biological rel-
atives and then assume that they can be explained par-
simoniously by an additive genetic contribution and a
common household contribution, without having to
make other assumptions of the mixed linear model.
Familial Risk Ratios Estimation
Familial risk ratios (lR) were estimated, as described
elsewhere (Risch 1990). In brief, lR is the risk of type-
R relatives of affected individuals of being affected them-
selves, divided by the population-prevalence frequency
(K). If the frequency of affected pairs with relationship
R is denoted by K2, then (Risch 1990).
2l p K /KR 2
Linkage Analysis
Nonparametric linkage (NPL) analysis.— Affected rel-
ative pair (ARP) analysis was done by use of the NPL
analysis implemented in GENEHUNTER (Kruglyak et
al. 1996). Like other ARP methods, the NPL statistic
measures allele sharing among the affected individuals
within a pedigree (Kruglyak et al. 1996). The scoring
function statistic was used to evaluate, simultaneously,
allele sharing among all those affected in a nuclear fam-
ily, in contrast to pairwise comparison. Both two-point
and multipoint NPL analyses were performed. This scor-
ing function was asymptotically distributed as the Z
statistic.
Model-based linkage analysis.— Two-point linkage
analysis between the underlying disease locus and each
marker was performed using LINKAGE version 5.2 (La-
throp et al. 1985). Multipoint LOD scores were com-
puted using SimWalk2 (Lange and Sobel 1991), with
input ﬁles automatically made by Mega2 version 2.5
(Mukhopadhyay et al. 1999). An autosomal-dominant
inheritance mode was assumed for the putative disease
locus, and penetrance was set at 0.95 on the basis of
observations of the high frequencies of affected persons
in at-risk sibships within pedigrees. The frequency of the
disease allele was set to 0.001. The allele frequencies of
markers were 1/n, where n is the number of alleles
observed.
Results
Familial Aggregation Analysis
Familial aggregation analysis (table 2) yielded corre-
lation coefﬁcients (r) for pedigree relatives at four levels
of degrees, consisting of 14 major relative-types. The
correlations for sibling relationship are intraclass cor-
relations, and those for other relationships are interclass
correlations. Statistical tests, against the null hypothe-
sis of zero correlation, were conducted by a t test using
the asymptotic SE estimates supplied by SAGE FCOR
(SAGE 2003).
For the ﬁrst-degree relative pairs (918 pairs), rp
; for the second-degree relative pairs (1,205 pairs),0.17
; for the third-degree relative pairs (1,243rp 0.04
pairs), ; and, for the fourth-degree relative pairsrp 0.09
(1,412 pairs), (table 2). These results suggestrp 0.06
a strong familial aggregation of RLS in this ascertained
cohort. The correlation estimates between the same-gen-
der pairs of individuals were higher than those between
individuals of the opposite sex, with brother-brother
pairs having the highest correlation ( ), followedrp 0.48
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Figure 1 Genomewide NPL scan for RLS-susceptibility loci. A total of 404 microsatellite markers spanning the entire human genome
were genotyped in 144 individuals frommultiplex RLS families. The verticalY-axis of each plot denotesNPL scores generatedbyGENEHUNTER.
The X-axis represents marker map positions in cM from the telomere of the p arm of each chromosome. The horizontal solid line in each plot
corresponds to an NPL score of 3.0.
by sister-sister pairs ( ), and sister-brother pairsrp 0.39
having the lowest correlation ( ), which mayrp 0.19
suggest a sex-linked effect for the disorder. There is a
considerable negative correlation between spouses
( ), which may reﬂect the lower risk of RLSrp 0.41
among the spouses who married into the family (5%–
12%) than in the ascertained families (29.6%). The de-
rived heritability, estimated by combining all informa-
tion from all types of relative pairs, was 0.60, which
indicates that RLS is a highly heritable trait in this as-
certained cohort.
We also estimated familiar relative risk ratios for the
ﬁrst-degree relative pairs using Risch’smodel (1990). For
a conservative estimate, a high-population prevalence
rate of 12% was used in the calculation. The absolute
risks, in terms of the concordance rate of affected status
between the pairs, were 23% for parent-offsprings,
whose , and 15% for siblings, whosel p 10.25 l pR R
. These results are in agreement with FCOR cor-16.23
relations-analysis and suggest that there is a strong fa-
milial aggregation in the RLS families studied.
Model-Free Linkage Analysis
Genomewide NPL analysis of our RLS cohort was
conducted using GENEHUNTER. The chromosomal
regions identiﬁed as “potentially interesting” with a
peak NPL score of 12.0 (Kruglyak et al. 1996) are listed
in table 3 and shown in ﬁgure 1. Ten markers on ﬁve
different chromosomes (chromosomes 3, 4, 5, 6, 9) gen-
erated multipoint NPL scores 12.0 (table 3; ﬁg. 1). The
highest NPL scores, 3.22 and 2.87, were obtained for
two markers, D9S286 and GATA187D09, that are sep-
arated by 4.1 cM on chromosome 9p24-22. The linkage
to another marker, GATA27A11 (D9S925) which is 10.1
cM to GATA187D09, remains positive for linkage, with
an NPL score of 1.69. Then, a permutation test with up
to 10,000 permutations was performed using SimWalk2
(Lange and Sobel 1991). A pointwise empirical P value
of .009 was obtained for this 9p24-22 RLS locus.
Model-Based Linkage Analysis
To validate the results fromNPL analysis, we analyzed
chromosomal regions with NPL scores 12.0 by use of
model-based linkage analysis. The results from two ex-
tended RLS families, 40004 and 40015, conﬁrmed the
existence of the chromosome 9p24-22 locus that was
identiﬁed by model-free linkage analysis (table 4). The
results of two-point linkage analysis with selected mark-
ers at the chromosome 9p24-22 locus are shown in table
4. Combined two-point LOD scores of 3.77 and 3.24,
at a recombination fraction of zero, were obtained for
two nearby markers, D9S286 and D9S274, respectively,
on the assumption of an autosomal-dominant mode of
inheritance (table 4).
Fine mapping was performed with additional markers
D9S1779, D9S1871, D9S2169, D9S168, D9S268,
D9S1839, D9S162, and D9S1121 at the chromosome
9p24-22 RLS locus. Multipoint LOD scores for the re-
gion were obtained using SimWalk2 (Lange and Sobel
1991) for random walk analysis of multiple marker in-
formation, and the resulting scores are shown in ﬁgure
2. The peak multipoint LOD score of 3.9 was obtained
from marker D9S2169 to D9S286 (ﬁg. 2).
Haplotype transmission-pattern analysis further val-
idated the mapping of a novel RLS locus to chromo-
some 9p24-22 (ﬁgs. 3 and 5). In kindred 40004, all affec-
ted individuals—but none of the normal individuals—
carried a common haplotype, 2_2_3_5_2_2_1_1 for
the eight contiguous markers D9S1779, D9S1871,
D9S2169, D9S286, D9S168, D9S268, D9S274 and
D9S1839 (ﬁg. 3). The common haplotype shared by all
affected individuals in kindred 40015—but not by any
normal individuals—was 3_2_3_3_2_2_3_10 for the
eight contiguous markers D9S1871, D9S2169, D9S286,
D9S168, D9S268, D9S274, D9S1839, and D9S162.
Two obligate recombination events, one in kindred
40004 (individual III-1; ﬁg. 3) and the other in kindred
40015 (individual II-1; ﬁg. 4), deﬁned the critical 9p24-
22 RLS disease gene within a region spanned by markers
D9S1779 and D9S162 (ﬁg. 5).
Discussion
This study represents the ﬁrst model-free linkage analysis
designed to genetically dissect the complex disease RLS
and to identify genetic loci causing susceptibility to RLS.
Our study provided signiﬁcant evidence of linkage for
a novel disease-susceptibility RLS locus on chromosome
9p24-22. Model-free multipoint linkage analysis re-
vealed an NPL score of 3.22 at marker D9S286. The
permutation tests by SimWalk2 revealed an empirical
pointwise P value of .009. Later, model-based linkage
analysis with the assumption of an autosomal-dominant
mode of inheritance resulted in a multipoint LOD score
of 3.91 at D9S286 in two extended families. These re-
sults validate the identiﬁcation of the signiﬁcant linkage
to RLS on chromosome 9p24-22.
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Figure 2 Multipoint LOD-score analysis for markers at the 9p 24.2–22.3 RLS locus. Random walk analysis was done using SimWalk2.
Location of marker D9S1779 is arbitrarily set at 0 cM. Other microsatellite markers are scaled on the basis of their absolute distance (in cM)
from D9S1779. Multipoint LOD scores are plotted on the ordinate. The dashed line marks an LOD score of 3.0.
Two other model-based linkage analyses were re-
cently reported for RLS. Desautels et al. (2001) iden-
tiﬁed an autosomal-recessive RLS locus on chromosome
12q22–23 in a single family, and Bonati et al. (2003)
mapped an autosomal-dominant RLS locus to chro-
mosome 14q13–21, also in a single family. In our
model-free linkage analysis, no markers on chromo-
some 14q yielded an NPL score 11.0 (ﬁg. 1). Interest-
ingly, marker PAH yielded an NPL score of 1.29 in our
model-free linkage analysis (ﬁg. 1). As PAH is located
within the 12q22-23 RLS-locus between D12S1044 and
D12S78 and is 2.4 cM to marker D12S78, our results
may provide indirect conﬁrmation of the mapping of
an RLS gene on chromosome 12q22-23, reported else-
where (Desautels et al. 2001). Identiﬁcation of three
genetic loci for RLS on three different chromosomes,
12q22-23 (Desautels et al. 2001), 14q13-21 (Bonati et
al. 2003), and 9p24-22 (this study), suggests that RLS
is a genetically highly-heterogeneous disorder.
Twin studies (Ondo et al. 2000) and the observation
that ∼65% of patients report a family history of RLS
(Montplaisir et al. 1997; Lazzarini et al. 1999; Roth-
dach et al. 2000; Allen et al. 2002; Winkelmann et al.
2002) suggest that genetic factors contribute to the
pathogenesis of RLS. However, few formal epidemio-
logical and statistical studies have been performed to
elucidate the genetic architecture of this complex dis-
ease. This study reports such a formal analysis. A high,
positive r of 0.17 between the ﬁrst-degree relatives sug-
gests their strong phenotypic resemblance. Furthermore,
the heritability of RLS was estimated to be a very high
value of 0.60 for all types of relative pairs. These results
indicate that RLS is a highly heritable trait in this as-
certained cohort. It is interesting that the correlations
for relative pairs were higher for siblings than for par-
ent-offspring pairs and were highest for same-sex sib-
lings. This suggests that gender and other environmental
factors are involved in RLS and that our estimate may
represent an upper limit of the degree of heritability
that may include a part of shared common environment.
It is important to note that familial correlations and
heritability were estimated for an ascertained cohort,
and the results may not be generalizable to the RLS
population at large.
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Figure 3 Haplotype analysis in kindred 40004 affected with
RLS. Circles and squares denote females andmales, respectively; black-
ened symbols indicate affected individuals; unblackened symbols in-
dicate normal individuals; the symbol with a slash indicates a deceased
individual; and symbols with a question mark indicate an individual
with uncertain phenotype. Genotyping results for markers D9S1779,
D9S1871, D9S2169, D9S286, D9S168, D9S268, D9S274, D9S1839,
D9S162, and D9S1121 are shown under each symbol. Haplotypes
were constructed on the basis of the minimum number of recombi-
nations between markers. The disease haplotype shared by all affected
individuals is denoted by the blackened vertical bar, and normal hap-
lotype is denoted by an unblackened vertical bar. Recombination
events were observed in individuals III-1, III-2, and III-3 and deﬁned
the critical RLS gene location as upward from marker D9S162.
Figure 4 Haplotype analysis in kindred 40015 affected with
RLS. Data are shown as described in ﬁg. 3. Two recombination events
were observed, one in individual II-1 and the other in III-1. The obligate
recombination in II-1 deﬁned the RLS gene location as downward
from D9S1779.
The 9p24-22 RLS locus contains 1100 genes (NCBI
Human Genome Resources; UCSC Genome Bioinfor-
matics). Among the genes in the region, we selected
three genes for mutation analysis on the basis of their
locations and physiology. Multi-PDZ Domain Protein
1 (MUPP1 [MIM 603785]) is a gene encoding a protein
with 13 PDZ domains that interacts with the C-terminal
domain of the serotonin 5-HT2C receptor (Ullmer et al.
1998). It was isolated in a yeast two-hybrid screening
with the C-terminal domain of the 5-HT2C receptor as
the bait. MUPP1 is expressed in the brain and in several
peripheral organs. MUPP1 might be involved in the
mechanisms of G–protein-coupled receptor signaling,
for example, the 5-HT2C receptor-activated phosphoi-
nositide-linked second message system. Thus, MUPP1
became a candidate gene for RLS. All 44 exons of
MUPP1, including exon-intron boundaries, were
screened for RLS-related mutations by use of direct
DNA-sequence analysis and single-strand conformation
polymorphism analysis, but no disease-causing muta-
tions were found.
The second candidate gene is SLC1A1 (MIM
133550), which encodes the human high-afﬁnity neu-
ronal and epithelial glutamate transporter EAAC1. The
function of EAAC1 is to transport L-glutamate and also
L- and D-aspartate, a function that is essential for ter-
minating the postsynaptic action of glutamate by rap-
idly removing released glutamate from the synaptic
cleft. It acts as a symport by cotransporting sodium.
EAAC1(EAAT3) mRNA and protein expressionwas de-
tected in both brain and peripheral tissues. All 12 exons
884 Am. J. Hum. Genet. 74:876–885, 2004
Figure 5 Ideogram of chromosome 9 with Geimsa banding and
localization of the 9p24-22 RLS locus. The genetic map with chro-
mosome 9p24-22 markers is shown, and the likely location of the
putative RLS gene is indicated by a vertical bar (from D9S1871 to
D9S1839).
of the SLC1A1 gene, including all exon-intron bound-
aries, were screened for mutations in RLS patients, but
none were found. Furthermore, no disease-causing mu-
tations were identiﬁed in the third candidate gene,
KCNV2 (MIM 607604), which encodes a potassium-
channel subunit that mediates the voltage-dependent
potassium-ion permeability of excitable membranes.
Continued mutation analysis in candidate genes that
are located within the 9p24-22 RLS locus and that play
a role in neuronal signaling, iron metabolism, and do-
paminergic function will lead to the identiﬁcation of an
underlying major (or minor) gene for common disease
RLS. Identiﬁcation of an RLS gene should provide in-
sights into the molecular mechanism for the pathogen-
esis of RLS.
Acknowledgments
We thank James Weber and the National Heart, Lung, and
Blood Institute Mammalian Genotyping Service for help with
genotyping; Jane Lu, Xiangdong Qu, Emily Kan, Glendaliz
Bosques, and Danmei Zhang for technical help; and Joseph
Jankovic, Director of the Baylor College of Medicine Parkin-
son Disease Center and Movement Disorder Clinic, for advice
and discussion. This study was supported by Lerner Research
Institute Seed Funds (Q.W.) and in part by NIH grants R01
HL65630 and R01 HL66251 (Q.W.).
Electronic-Database Information
Accession numbers and URLs for data presented herein are
as follows:
GENEHUNTER, http://linkage.rockefeller.edu/soft/gh/ or
http://www.hgmp.mrc.ac.uk/About/Courses/2003/comp
.linkage/genehunt.html
Human Genome Resources, http://www.ncbi.nlm.nih.gov/
genome/guide/human/
Marshﬁeld Medical Research Foundation, http://research
.marshﬁeldclinic.org/genetics/
Mega2 version 2.5 (2001), http://watson.hgen.pitt.edu/mega2
.html
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim
UCSC Genome bioinformatics, http://genome.ucsc.edu/
References
Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ (2001) MRI
measurement of brain iron in patients with restless legs syn-
drome. Neurology 56:263–265
Allen RP, Earley CJ (2001) Restless legs syndrome: a review
of clinical and pathophysiologic features. J Clin Neurophy-
siol 18:128–147
Allen RP, La Buda MC, Becker P, Earley CJ (2002) Family
history study of the restless legs syndrome. Sleep Med Suppl
3:S3–S7
Allen RP, Kushida CA, Atkinson MJ (2003a) Factor analysis
of the International Restless Legs Syndrome Study Group’s
scale for restless legs severity. Sleep Med 4:133–135
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters
AS, Montplaisi J (2003b) Restless legs syndrome: diagnostic
criteria, special considerations, and epidemiology. A report
from the restless legs syndrome diagnosis and epidemiology
workshop at the National Institutes of Health. Sleep Med
4:101–119
Bonati MT, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M,
Casari G (2003) Autosomal dominant restless legs syndrome
maps on chromosome 14q. Brain 126:1485–1492
Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada
P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-
Lopez R, Wang Z, Antzelevitch C, O’Brien RE, Schulze-Bahr
E, Keating MT, Towbin JA, Wang Q (1998) Genetic basis
and molecular mechanism for idiopathic ventricular ﬁbril-
lation. Nature 392:293–296
Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Ondo
Chen et al.: Susceptibility Locus for RLS on Chromosome 9p 885
WG, Earley CJ (2003) Neuropathological examination sug-
gests impaired brain iron acquisition in restless legs syn-
drome. Neurology 61:304–309
Desautels A, Turecki G, Montplaisir J, Sequeira A, Verner A,
Rouleau GA (2001) Identiﬁcation of a major susceptibility
locus for restless legs syndrome on chromosome 12q. Am J
Hum Genet 69:1266–1270
Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK,
Allen RP (2000) Abnormalities in CSF concentrations of
ferritin and transferrin in restless legs syndrome. Neurology
54:1698–1700
Hening WA, Allen RP (2003) Restless legs syndrome (RLS):
the continuing development of diagnostic standards and se-
verity measures. Sleep Med 4:95–97
Kageyama T, Kabuto M, Nitta H, Kurokawa Y, Taira K, Su-
zuki S, Takemoto T (2000) Prevalences of periodic limb
movement-like and restless legs-like symptoms among Jap-
anese adults. Psychiatry Clin Neurosci 54:296–298
Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Para-
metric and nonparametric linkage analysis: a uniﬁed mul-
tipoint approach. Am J Hum Genet 58:1347–1363
Lange K, Sobel E (1991) A random walk method for com-
puting genetic location scores. Am J Hum Genet 49:1320–
1334
Lathrop GM, Lalouel JM, Julier C, Ott J (1985) Multilocus
linkage analysis in humans: detection of linkage and esti-
mation of recombination. Am J Hum Genet 37:482–498
Lazzarini A, Walters AS, Hickey K, Coccagna G, Lugaresi E,
Ehrenberg BL, Picchietti DL, Brin MF, Stenroos ES, Verrico
T, Johnson WG (1999) Studies of penetrance and antici-
pation in ﬁve autosomal-dominant restless legs syndrome
pedigrees. Mov Disord 14:111–116
Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O,
Lesperance P (1997) Clinical, polysomnographic, and ge-
netic characteristics of restless legs syndrome: a study of 133
patients diagnosed with new standard criteria. Mov Disord
12:61–65
Mukhopadhyay N, Almasy L, Schroeder M, Mulvihill WP,
Weeks DE (1999) Mega2, a data-handling program for fa-
cilitating genetic linkage and association analyses. Am J
Hum Genet 65:A436
Olson JM (1999) Relationship estimation by Markov-process
models in a sib-pair linkage study. Am J Hum Genet 64:
1464–1472
Ondo WG, Jankovic J (1996) Restless legs syndrome: clinical-
etiologic correlates. Neurology 47:1435–1441
Ondo WG, Vuong KD, Wang Q (2000) Restless legs syndrome
in monozygotic twins: clinical correlates. Neurology 55:
1404–1406
Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C
(2000) Epidemiology of restless legs symptoms in adults.
Arch Intern Med 160:2137–2141
Picchietti DL, England SJ, Walters AS, Willis K, Verrico T
(1998) Periodic limb movement disorder and restless legs
syndrome in children with attention-deﬁcit hyperactivity dis-
order. J Child Neurol 13:588–594
Risch N (1990) Linkage strategies for genetically complex
traits. I. Multilocus models. Am J Hum Genet 46:222–228
Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K
(2000) Prevalence and risk factors of RLS in an elderly pop-
ulation: the MEMO study. Memory and morbidity in Augs-
burg elderly. Neurology 54:1064–1068
SAGE (2003) Statistical analysis for genetic epidemiology. Sta-
tistical solutions, Cork, Ireland
Tan EK, Ondo W (2000) Restless legs syndrome: clinical fea-
tures and treatment. Am J Med Sci 319:397–403
Ulfberg J, Nystrom B, Carter N, Edling C (2001a) Prevalence
of restless legs syndrome among men aged 18 to 64 years:
an association with somatic disease and neuropsychiatric
symptoms. Mov Disord 16:1159–1163
Ulfberg J, Nystrom B, Carter N, Edling C (2001b) Restless
legs syndrome among working-aged women. Eur Neurol 46:
17–19
Ullmer C, Schmuck K, Figge A, Lubbert H (1998) Cloning
and characterization of MUPP1, a novel PDZ domain pro-
tein. FEBS Lett 424:63–68
Walters AS (1995) Toward a better deﬁnition of the restless
legs syndrome: the International Restless Legs Syndrome
Study Group. Mov Disord 10:634–642
Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen
RP, Trenkwalder C (2003) Validation of the International
Restless Legs Syndrome Study Group rating scale for restless
legs syndrome. Sleep Med 4:121–132
Wang L, Fan C, Topol SE, Topol EJ, Wang Q (2003) Mutation
of MEF2A in an inherited disorder with features of coronary
artery disease. Science 302:1578–1581
Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM,
VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager
T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes
GM, Connors TD, Keating MT (1996) Positional cloning
of a novel potassium channel gene: KVLQT1 mutations
cause cardiac arrhythmias. Nat Genet 12:17–23
Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL,
Moss AJ, Towbin JA, KeatingMT (1995) SCN5Amutations
associated with an inherited cardiac arrhythmia, long QT
syndrome. Cell 80:805–811
Weber JL, Broman KW (2001) Genotyping for human whole-
genome scans: past, present, and future. Adv Genet 42:77–
96
Winkelmann J, Muller-Myhsok B, Wittchen HU, Hock B, Pra-
ger M, Pﬁster H, Strohle A, Eisensehr I, Dichgans M, Gasser
T, Trenkwalder C (2002) Complex segregation analysis of
restless legs syndrome provides evidence for an autosomal
dominant mode of inheritance in early age at onset families.
Ann Neurol 52:297–302
